The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

The FDA has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), a new subcutaneous injection formulation of Opdivo.

(HealthDay News) — Surgical residency programs can improve working environments using Lean methodology, according to a study published online in JAMA Surgery.

Dietary acid load has been implicated in chronic kidney disease (CKD), but reducing it can provide kidney protection.

Consuming grape juice 5 times or more per week was associated with 79% reduced odds of erectile dysfunction compared with no ...

Time burdens associated with cancer care extend beyond the burden of time spent accessing care outside the home.

(HealthDay News) — The A (H5N1) virus generally causes mild illness of short duration, mainly among U.S. adults exposed to infected animals, according to a study published online in the New England ...

Pain coping skills training is beneficial for patients undergoing maintenance hemodialysis and experiencing chronic pain.

Men with negative multiparametric magnetic resonance imaging results avoiding biopsy do not have an increased risk for clinically significant prostate cancer.

A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...

Patients on hemodialysis diagnosed with cancer have a 3-year survival rate similar to that of individuals with cancer in the general population.

The prognosis of acute kidney injury (AKI) in ICU patients might be indicated by levels of a complement factor B fragment.